Advertisement

Reactions Weekly

, Volume 1777, Issue 1, pp 195–195 | Cite as

Pembrolizumab

Peripheral T-cell lymphoma: case report
Case report
  • 15 Downloads

Reference

  1. Anand K, et al. Tcell lymphoma secondary to checkpoint inhibitor (CPI) used for other malignancies. Journal of Clinical Oncology 37 (Suppl. 8): abstr. 88, 10 Mar 2019. Available from: URL: http://doi.org/10.1200/JCO.2019.37.8_suppl.88 [abstract] - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations